Sotera Health Q1 Revenue Forecast at $270M, EPS Seen $0.09
Sotera Health projects Q1 2026 revenue of $270 million with EPS of $0.09, against full-year revenue forecast of $1.24 billion and EPS of $0.62. Analysts have raised 2026 revenue estimates by $10 million over 90 days but cut full-year EPS forecasts from $0.75 to $0.62.
1. Q1 2026 Earnings Preview
Sotera Health will report Q1 2026 results on May 5, forecasting revenue of $270 million and EPS of $0.09.
2. Estimate Revisions
Over the past 90 days, full-year 2026 revenue projections rose from $1.23 billion to $1.24 billion, while EPS forecasts declined from $0.75 to $0.62; 2027 revenue and EPS estimates saw similar adjustments.
3. Q4 2025 Actuals
In Q4 2025, the company posted $300 million in revenue, beating estimates by 1.3%, but reported EPS of $0.12, missing expectations by 35.3%, which drove a 4.4% stock pullback the following day.
4. Analyst Price Targets & Ratings
Nine analysts set an average one-year price target of $20.83, ranging from $16.00 to $24.00, implying 34.4% upside, while brokerage consensus stands at an Outperform rating of 1.7 on a 1–5 scale; proprietary valuation suggests a $17.55 fair value.